Cipla Announces Settlement of REVLIMID® (lenalidomide) Capsules Patent Litigation
Go back to Cipla Announces Settlement of REVLIMID® (lenalidomide) Capsules Patent Litigation| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 67.00 -1.09 (1.6%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $68.09 | 52 Week High | $77.12 | |||
| Open | $67.24 | 52 Week Low | $49.03 | |||
| Day High | $67.72 | P/E | 43.51 | |||
| Day Low | $66.73 | EPS | $1.54 | |||
| Volume | 1,417,705 | |||||
| Celgene Corp. (NASDAQ: CELG) | Delayed: 108.24 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $108.24 | 52 Week High | $127.00 | |||
| Open | $7.85 | 52 Week Low | $93.05 | |||
| Day High | $108.24 | P/E | 32.12 | |||
| Day Low | $108.24 | EPS | $3.37 | |||
| Volume | 0 | |||||
